Achieving the Exit with Dr. Hugh Rienhoff & FerroKin

By SRS — 3 years ago

Shareholder Representative Services’ latest Q&A features Dr. Hugh Rienhoff.  Rienhoff led FerroKin to an acquisition by Shire valued at up to $325 million. Trained as a physician, Rienhoff spent eight years working as a scientist and eight years as a venture capitalist focused on biotechnology prior to becoming an entrepreneur.

Continue

Achieving the Exit with Amr Salahieh & Shifamed

By SRS — 4 years ago

Shareholder Representative Services’ latest Q&A features Amr Salahieh.  Salahieh is the founder of Shifamed LLC, a Silicon Valley-based medical device incubator founded in 2009. Shifamed recently sold Maya Medical, a medical device company focused on the treatment of hypertension, to Covidien in a deal valued at up to $230 million. Salahieh discusses the incubator model, […]

Continue

Achieving the Exit with Troy Wilson & Intellikine

By SRS — 4 years ago

Shareholder Representative Services’ latest Q&A features Troy Wilson.  Wilson led Intellikine to an acquisition by Millennium, a U.S. subsidiary of Takeda, for up to $310 million. As a serial entrepreneur, he looks for opportunities with clear value inflection points that bring discipline to the development process. He discusses his approach to value creation, the difference […]

Continue

Achieving the Exit with Steve Papa & Endeca

By SRS — 4 years ago

Shareholder Representative Services’ latest Q&A features Steve Papa.  Papa led Endeca, the Cambridge, Mass.-based provider of unstructured data management, web commerce and business intelligence software, to an acquisition by Oracle in December 2011. He emphasizes the “relentless pursuit of credibility” to best position a startup for hiring, customer acquisition, and ultimately, achieving the exit. Q: What […]

Continue